The Fed's preferred inflation gauge, the personal consumption and expenditures index, rose 0.3% from November and 2.6% ...
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.